Cefotaxime Sodium/Sulbactam sodium

头孢噻肟钠/舒巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCefotaxime Sodium/Sulbactam sodium
Drug Alias Name头孢噻肟钠舒巴坦钠
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsMeningitisEsophageal and Gastric VaricesUrinary Tract Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Cefotaxime SodiumSulbactam sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Youan Hospital, Capital Medical University
Inactive CompaniesN/A
Active IndicationsMeningitisEsophageal and Gastric VaricesUrinary Tract Infections +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A